文献速递糖尿病

芬兰1型糖尿病终末期肾病患者肾移植后长期死亡率

Long-term Mortality After Kidney Transplantation in a Nationwide Cohort of Patients With Type 1 Diabetes in Finland.
PubMed 文献 · Diabetes Care · 2018-11-02

芬兰全国性回顾性队列纳入2383例1型糖尿病合并终末期肾病患者,比较透析与肾移植后的生存及死因。成功移植后中位生存15.9年,移植失功后11.2年,持续透析仅2.9年;2005年后标准化死亡率比分别为3.9、11.5和32.5。缺血性心脏病为最常见死因(45%)。

要点

  • 肾移植是1型糖尿病合并终末期肾病的首选治疗,显著降低超额死亡风险。
  • 即使移植肾功能丧失,超额死亡风险仍明显低于持续透析。
  • 缺血性心脏病仍是首位死因,移植后仍需重视心血管风险管理。

核心结论

  • 肾移植是1型糖尿病合并终末期肾病的首选治疗,与透析相比大幅降低超额死亡风险。
  • 移植肾功能丧失后超额死亡风险仍显著低于持续透析。
  • 尽管总体死亡率下降,缺血性心脏病导致的早死仍处高位。

研究设计与样本

  • 芬兰全国性回顾性队列分析,纳入所有接受单纯肾移植的1型糖尿病患者并与持续透析者比较。
  • 共研究2383例患者,按透析、肾功能正常移植、移植失功后再透析分组。
  • 主要结局为开始透析后的患者生存,并检索死因、计算标准化死亡率比。

主要发现

  • 成功移植后中位生存15.9年,移植功能丧失后11.2年,持续透析仅2.9年。
  • 近四十年各亚组标准化死亡率比均下降;2005年起移植组3.9、移植失功组11.5、透析组32.5。
  • 全部患者最常见死因为缺血性心脏病(45%),其次为感染(18%),感染在透析患者中更常见。

临床怎么用

  • 对1型糖尿病合并终末期肾病患者,应积极评估肾移植以降低死亡风险。
  • 移植后及移植失功患者仍需强化缺血性心脏病风险管理。
  • 透析患者需关注感染相关死亡风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine time trends in mortality rates and causes of death in patients with type 1 diabetes and end-stage renal disease on dialysis and after kidney transplantation. RESEARCH DESIGN AND METHODS: In a nationwide retrospective cohort analysis, all patients with type 1 diabetes in Finland who received a kidney transplant alone were compared with patients who remained on dialysis. The main outcome was patient survival after starting dialysis. The cohort was divided into dialysis, functioning kidney transplant, and dialysis after transplant loss. Causes of death were retrieved and standardized mortality ratios calculated. RESULTS: We studied 2,383 patients. Patients survived a median of 15.9 years after a successful transplant, 11.2 years if transplant function was lost, and 2.9 years if they remained on chronic dialysis. Standardized mortality ratio decreased in all subgroups during the past four decades: from 2005 onwards, it was 3.9 in patients receiving a kidney transplant, 11.5 in patients with graft loss, and 32.5 in patients on dialysis. The most common cause of death in all patients was ischemic heart disease (45%) followed by infection (18%), which was more common in patients on dialysis. CONCLUSIONS: Kidney transplantation is the treatment of choice for patients with type 1 diabetes and end-stage renal disease because it substantially reduces the excess death risk when compared with dialysis. Even when kidney graft function is lost, the excess death risk is still considerably lower. Although overall mortality has decreased over the years, premature death due to ischemic heart disease remains high.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Ortiz F, Harjutsalo V, Helanterä I, et al. Long-term Mortality After Kidney Transplantation in a Nationwide Cohort of Patients With Type 1 Diabetes in Finland. Diabetes Care. 2018. PMID: 30389672. doi:10.2337/dc18-1029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。